Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (69)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Local invasion and distant metastasis are distinct
- E-cadherin mediates homotypic epithelial adhesion
- ECM degradation removes physical obstacles
- Reduced inhibitors reinforce ECM degradation
- Degradation and receptor binding reinforce one another
- Matrix cleavage products provide another cue
- A schematic boundary tests the concept of invasion
- Four-step mechanism at a glance
Slide index & full transcript (69 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Invasion of Extracellular Matrix
How carcinomas cross tissue barriers, reshape their microenvironment, and acquire motility
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Identify the successive extracellular barriers encountered by an invasive carcinoma.
Explain the four interdependent steps of extracellular matrix invasion.
Relate E-cadherin, proteases, integrins, and actin-based motility to invasive behavior.
Interpret stromal cooperation and the transition to intravasation.
Slide 3 · Local invasion and distant metastasis are distinct
Local invasion
Direct penetration of adjacent tissue compartments
Requires altered adhesion, ECM remodeling, and motility
Can destroy structures at the primary site
Distant metastasis
Requires additional vascular dissemination and colonization
Only a minority of entering tumor cells form deposits
Depends on interactions with distant host environments
Slide 4 · Invasion is an active cellular program
Carcinoma cells do not simply expand through a pre-existing opening.
They alter contacts with neighboring cells and extracellular matrix.
Proteolysis, receptor engagement, and movement are coordinated with stromal responses.
Schematic
Epithelial compartment
Epithelial basement membrane
Interstitial ECM
Vascular compartment
A breached boundary requires tumor-cell behavior—not growth alone.
Slide 5 · Two extracellular matrix compartments
Basement membrane
Separates epithelial and vascular compartments from adjacent tissue
Contains type IV collagen and laminin
An early and later barrier to disseminating cells
Interstitial connective tissue
Lies between epithelial structures and blood vessels
Includes collagens, glycoproteins, and proteoglycans
Must be crossed during movement toward a vessel
Slide 6 · The epithelial basement membrane defines a boundary
The basement membrane separates epithelial cells from the underlying connective tissue.
Carcinoma invasion requires penetration of this barrier.
Matrix organization also shapes cell attachment, signaling, and polarity.
Schematic
Epithelial compartment
Epithelial basement membrane
Interstitial connective tissue
Normal boundary
Crossing an epithelial basement membrane is a topologic change.
Slide 7 · Interstitial matrix is more than empty space
Connective tissue matrix occupies the path between an epithelial tumor and its vascular access.
Its constituents provide both physical resistance and binding sites for cells.
Matrix cleavage creates a route and biologically active fragments.
Schematic
Epithelial compartment
Epithelial basement membrane
Interstitial connective tissue
Slide 8 · The route from epithelium to circulation
Epithelial basement membrane
Interstitial connective tissue
Vascular basement membrane
Vascular lumen
In a distant organ, exiting the vessel requires barrier traversal in reverse.
Slide 9 · Matrix components have structural and signaling roles
Structural barrier
Type IV collagen supports basement membranes
Interstitial matrix maintains tissue compartmentation
Continuity limits unrestrained tissue traversal
Biologic interface
Laminin and collagen serve as receptor ligands
Proteolysis uncovers additional binding sites
Stored growth factors can be released by degradation
Slide 10 · Four linked steps drive local invasion
Loosen cell–cell contacts
Proteolytically degrade ECM
Attach to remodeled matrix
Migrate through tissue
The steps cooperate; The diagram is a teaching sequence, not four isolated switches.
Slide 11 · Adhesion loss enables tumor-cell detachment
Normal epithelial cells maintain strong cell–cell junctions.
Altered intercellular adhesion can dissociate tumor cells from one another.
This is the initiating step in the Robbins four-step model of invasion.
Schematic
Cell–cell adhesion
Dissociation
Slide 12 · E-cadherin mediates homotypic epithelial adhesion
E-cadherin is a transmembrane glycoprotein expressed by epithelial cells.
Its interactions help preserve cohesion between cells of the same epithelial compartment.
Disruption of its function weakens the contacts that restrain dissociation.
Schematic
Homotypic E-cadherin bonds
Cohesive epithelium
Slide 13 · E-cadherin also transmits intercellular signals
E-cadherin participates in signaling as well as physical adhesion.
Loss of function affects coordinated epithelial behavior, not only mechanical cohesion.
Adhesion molecules therefore connect tissue architecture to cell phenotype.
Schematic
Cell–cell adhesion
Adhesion-linked signaling
Slide 14 · Two paths to impaired E-cadherin function
E-cadherin mutation in selected epithelial tumors
Functional loss or expression silencing
Weakened tumor-cell cohesion
Greater opportunity for dissociation
The source describes both genetic loss and hypothesized, sometimes transient, silencing.
Slide 15 · Loss-of-function mutations are tumor-specific examples
Certain gastric and breast adenocarcinomas with E-cadherin loss due to mutation.
This is not presented as a universal mechanism in every carcinoma.
Many other epithelial cancers may reduce E-cadherin through different regulatory routes.
Schematic
Mutation
Expression silencing
E-cadherin function decreases
Weakened cell–cell adhesion
Slide 16 · Epithelial–mesenchymal transition is a proposed route
Epithelial–mesenchymal transition (EMT) changes epithelial-marker expression and motility-associated traits.
That EMT contributes to carcinoma invasion and metastasis.
Its role is expressed as a hypothesis, not an invariant requirement for all metastases.
Schematic
Epithelial state
Mesenchymal traits
E-cadherin ↓
Vimentin ↑
Smooth muscle actin ↑
More migratory potential
Slide 17 · SNAIL and TWIST participate in EMT regulation
The transcription factors SNAIL and TWIST are named regulators of the EMT program.
Their activity is linked to altered epithelial and mesenchymal marker expression.
The phenotypic consequence is thought to favor a migratory carcinoma cell.
Schematic
SNAIL / TWIST
Marker-expression changes
Promigratory phenotype
Slide 18 · EMT changes a coordinated marker pattern
Epithelial-associated
E-cadherin expression
Cohesive cell–cell interactions
Maintained epithelial organization
Mesenchymal-associated
Vimentin expression
Smooth muscle actin expression
Promigratory traits
Markers describe a coordinated phenotype; No single marker establishes metastatic behavior.
Slide 19 · EMT links transcription to cellular behavior
SNAIL / TWIST activity
Reduced epithelial markers
Increased mesenchymal markers
Promigratory phenotype
The causal framing follows the hypothesized mechanism.
Slide 20 · EMT is not identical to successful metastasis
Enhanced motility helps local tissue invasion but does not guarantee distant colonization.
The metastatic cascade also requires circulation, survival, homing, and growth.
Different tumor-cell phenotypes and even cohesive groups may participate.
Schematic
Local ECM invasion
Circulation
Distant colonization
Separate later steps
Slide 21 · Adhesion changes create an invasive opportunity
A carcinoma retains proliferation but shows reduced intercellular cohesion. Which invasion step is directly facilitated?
Mechanistic interpretation
The first step: Loosening tumor cell–tumor cell interactions.
Reduced cohesion alone does not demonstrate ECM proteolysis or migration.
Additional processes are required to breach the basement membrane.
Slide 22 · ECM degradation removes physical obstacles
Proteolysis acts on epithelial basement membrane and interstitial connective tissue.
Breaches in matrix permit tumor cells to enter neighboring tissue compartments.
The same principle applies when approaching a vascular basement membrane.
Schematic
Extracellular matrix barrier
Tumor / stromal proteases
Matrix breach / remodeled ECM
Slide 23 · Proteases originate from tumor cells and stroma
Tumor-cell contribution
Secretion of matrix-degrading proteases
Signals that induce protease release from stroma
Participation in remodeling at the invasion front
Stromal contribution
Fibroblasts can produce proteases
Inflammatory cells can produce proteases
The tumor microenvironment participates actively
Slide 24 · Three protease systems highlighted by Robbins
Matrix metalloproteinases
Remodel basement membrane and interstitial matrix
Cathepsin D
A protease implicated in tumor-cell invasion
Urokinase plasminogen activator
A proteolytic system implicated in tumor-cell invasion
Slide 25 · Matrix metalloproteinases do more than digest
MMP-mediated ECM cleavage
Physical remodeling of barriers
Release of matrix-held factors
Generation of signaling fragments
Proteolysis is simultaneously structural remodeling and biologic signaling.
Slide 26 · MMP9 acts on type IV collagen
MMP9 is described as a gelatinase that cleaves type IV collagen.
Type IV collagen is present in epithelial and vascular basement membranes.
This action supports penetration of basement-membrane barriers.
Schematic
Type IV collagen (basement membrane)
MMP9
Matrix breach / remodeled ECM
Slide 27 · Epithelial and vascular basement membranes share vulnerability
At the primary epithelium
Basement-membrane cleavage permits invasion into stroma
Loss of compartment boundary enables local tissue infiltration
At the vessel
Vascular basement-membrane remodeling assists entry
Subsequent endothelial transmigration gives vascular access
Slide 28 · MMP9 can mobilize matrix-sequestered VEGF
ECM can retain vascular endothelial growth factor (VEGF).
MMP9-mediated release of VEGF from these stores.
Thus matrix degradation can contribute to an angiogenic microenvironment.
Schematic
ECM-bound VEGF
MMP9 proteolysis
Released VEGF
Angiogenic signaling
Slide 29 · ECM cleavage products can act as signals
Cleavage of collagen and proteoglycans yields matrix-derived fragments.
Some products with chemotactic, angiogenic, and growth-promoting effects.
Degradation products can therefore influence subsequent cell behavior.
Schematic
Chemotactic / angiogenic / growth effects
Slide 30 · Protease activity reflects a balance
Protease abundance or activity
Reduced metalloproteinase inhibition
Net increase in matrix proteolysis
Greater potential for tissue remodeling
A greater net proteolytic drive favors invasion; The model is qualitative.
Slide 31 · Reduced inhibitors reinforce ECM degradation
Several cancers show decreased concentrations of metalloproteinase inhibitors.
Lower inhibition shifts the local balance toward proteolysis.
Invasion depends on the functional protease–inhibitor relationship, not a single enzyme in isolation.
Schematic
Protease activity
Inhibitor activity
Net ECM degradation reflects the balance
More degradation when proteolysis predominates
Slide 32 · MMP9 differs qualitatively by tumor behavior
Benign tumors
Little MMP9 activity in benign breast, colon, and stomach tumors.
This is a qualitative tissue comparison.
Malignant counterparts
The corresponding malignant tumors may overexpress MMP9.
The text provides no numerical test cutoff.
Do not infer a stand-alone diagnostic MMP9 threshold from this comparison.
Slide 33 · Proteolysis and motility must cooperate
Suppose matrix breakdown is extensive, but tumor cells cannot form new ECM attachments. What step remains impaired?
Mechanistic interpretation
Attachment to remodeled ECM components is still deficient.
Proteolysis alone does not provide traction for locomotion.
The sequence requires coordinated receptor binding and actin-based movement.
Slide 34 · Integrins link tumor cells to extracellular matrix
Integrins are transmembrane receptors that bind components of ECM.
They mediate adhesion and transmit intracellular signals.
Changes in integrin expression or localization alter tumor–matrix interactions.
Schematic
Integrin–ECM interactions
Receptors transmit matrix-derived signals
Slide 35 · Normal epithelial integrins are basally restricted
Basal integrins bind basement-membrane laminin and collagens.
Their polarized distribution supports the resting state of epithelial cells.
Loss of normal polarity is part of altered neoplastic cell–matrix interaction.
Schematic
Basal receptor polarity
Attachment supports epithelial polarity
Slide 36 · Cancer cells alter the integrin repertoire
Complex changes in integrin expression during invasion.
Alternative integrins can support attachment under abnormal ECM conditions.
Some integrin signals also promote survival when normal adhesion is lost.
Schematic
Altered integrin engagement
Different receptors can support survival
Slide 37 · Normal detached cells may undergo anoikis
Normal epithelial cells depend on appropriate ECM attachment.
Loss of adhesion can trigger a form of apoptosis termed anoikis.
Anoikis helps distinguish normal attachment dependence from free tumor-cell survival.
Schematic
Detached epithelial cell
Anoikis (apoptosis)
Slide 38 · Anoikis resistance favors invasive survival
Tumor cells may survive despite losing their customary matrix contacts.
This in part to alternative integrins delivering survival signals.
Resisting anoikis is useful as cells detach and traverse changing ECM niches.
Schematic
Detached epithelial cell
Alternative integrin survival signals
Slide 39 · MMP2 and MMP9 expose new attachment sites
MMP2 or MMP9 cleavage can modify type IV collagen and laminin.
Proteolysis creates novel sites that tumor-cell receptors can bind.
The newly available contacts may stimulate cell migration.
Schematic
MMP2 / MMP9 cleavage
Novel ligand sites
Tumor receptor binding
Slide 40 · Degradation and receptor binding reinforce one another
Proteases remodel collagen IV / laminin
Novel ECM binding sites appear
Altered tumor-cell receptors engage matrix
Migration signaling is supported
The matrix becomes an active migration substrate after remodeling.
Slide 41 · ECM serves as both barrier and migratory track
Before remodeling
Intact architecture separates tissue compartments
Polarized attachment supports epithelial organization
After remodeling
Proteolysis opens passages and exposes ligands
Tumor cells can attach to altered matrix and move
Slide 42 · Why detachment alone is insufficient
A cell loses E-cadherin but remains sensitive to anoikis. What limits its invasive fitness?
Mechanistic interpretation
Cell–cell dissociation may occur, but ECM detachment can still trigger apoptosis.
Resistance to anoikis provides a survival advantage under altered attachment.
Adhesion, survival, and movement are separate requirements.
Slide 43 · Locomotion closes the four-step invasion sequence
The final step is tumor-cell movement through regions of matrix breakdown.
Movement requires receptor signals and the actin cytoskeleton.
Adhesion must be dynamically assembled and disassembled.
Schematic
Matrix anchoring
Coordinated movement
Direction of movement →
Slide 44 · The migrating cell has a front and a rear
The leading edge creates new attachments to matrix.
The trailing edge releases previous attachments.
Actin-based contractility enables net displacement through tissue.
Schematic
Rear detaches
Front attaches
Direction of movement →
Slide 45 · Leading-edge adhesion provides traction
A migrating tumor cell must bind the matrix ahead of its body.
Receptor engagement anchors the leading edge during movement.
Remodeled ECM provides potential sites for these new attachments.
Schematic
Leading-edge traction
New ECM contacts
Direction of movement →
Slide 46 · Trailing-edge release allows forward movement
Persistent adhesion at the cell rear would oppose net translation.
Migrating cells therefore detach matrix contacts at their trailing edge.
Turnover of cell–matrix contacts is as important as their formation.
Schematic
Rear release
Old contacts disassemble
Direction of movement →
Slide 47 · Actin contraction generates cell translocation
Multiple signaling pathways converge on the actin cytoskeleton.
Contractile movement can draw the cell body forward relative to anchored contacts.
Migration depends on spatial coordination, not simply stronger adhesion.
Schematic
Actin contraction
Cell-body movement
Direction of movement →
Slide 48 · Motility cues can be autocrine
Tumor cells can produce cytokines and chemokines that affect their own movement.
Robbins also cites growth factors, including insulin-like growth factors.
Such self-derived signals are described as autocrine motility factors.
Schematic
Self-derived chemokines / IGF
Slide 49 · Matrix cleavage products provide another cue
Degradation of collagen or laminin can release biologically active fragments.
These matrix-derived products may influence tumor-cell movement.
Thus the physical path and the local guidance environment change together.
Schematic
Collagen / laminin fragments
Motility cues
Slide 50 · Stromal HGF stimulates tumor-cell MET
Stromal hepatocyte growth factor (HGF), also called scatter factor, is a paracrine cue.
HGF binds MET, a receptor tyrosine kinase on tumor cells.
This pathway as promoting tumor-cell motility.
Schematic
Stromal cell
Tumor cell: MET
HGF / scatter factor
Increased motility
Slide 51 · Three sources of directional/motility signals
Tumor-derived
Chemokines and cytokines
Insulin-like growth factors
Autocrine stimulation
Matrix- and stroma-derived
Collagen / laminin cleavage products
Stromal HGF / scatter factor
Paracrine and matrix-associated stimulation
Slide 52 · The relevant motility cues vary across tumors
Robbins does not assign one universal chemokine or growth-factor pathway to every tumor.
Multiple receptors and signaling systems can converge on the cytoskeleton.
Different cancers may achieve migration using different combinations of cues.
Schematic
Tumor factors
Matrix fragments
Stromal HGF
Receptors → actin cytoskeleton
Slide 53 · Invasion is a tumor–stroma collaboration
Tumor cells interact with fibroblasts, inflammatory cells, immune cells, and endothelium.
Host-cell participation supplies proteases, ECM alterations, and motility cues.
Invasion is therefore not a solely tumor-cell-autonomous process.
Schematic
Fibroblast / immune cell
ECM / growth factors / proteases
Slide 54 · Cancer-associated fibroblasts remodel the niche
Invading cancer cells can change fibroblast gene-expression programs.
Cancer-associated fibroblasts alter ECM molecules, proteases, inhibitors, and growth factors.
These changes may build a local environment that supports malignant behavior.
Schematic
Cancer-associated fibroblast
ECM, proteases, inhibitors, growth factors
Slide 55 · Tumor and stroma influence one another
Invading tumor-cell signals
Altered stromal-cell phenotype
Changed ECM / protease / growth-factor output
Further support for tumor invasion
A reciprocal interaction, not a fixed one-way process.
Slide 56 · Immune and endothelial cells are part of the niche
Innate and adaptive immune cells among interacting stromal populations.
Endothelial cells form the next barrier to vascular entry.
The exact cell-specific mechanisms remain incompletely defined account.
Schematic
Epithelial compartment
Epithelial basement membrane
Interstitial connective tissue
Vascular compartment
Slide 57 · Intravasation is the local-phase endpoint
Invading carcinoma cells penetrate the endothelial basement membrane.
They then transmigrate into the vascular space.
After vascular entry, survival and distant colonization are separate steps of the metastatic cascade.
Schematic
Epithelial compartment
Epithelial basement membrane
Interstitial ECM
Vascular compartment
Slide 58 · Different barriers must be distinguished
Epithelial barrier
Basement membrane below the primary epithelium
Crossed during initial local invasion
Vascular barrier
Endothelium and its basement membrane
Crossed to reach the circulation
The first breach does not automatically mean intravasation.
Slide 59 · A schematic boundary tests the concept of invasion
In two conceptual epithelial lesions, one has an intact basement membrane and the other has tumor cells beyond it. Which depicts stromal invasion?
Mechanistic interpretation
Tumor cells beyond a breached epithelial basement membrane represent stromal invasion in this schematic.
This is a topological teaching example, not a patient specimen or full diagnostic rubric.
The same matrix interactions explain how cells then move toward vessels.
Slide 60 · Why high invasion does not imply high metastasis
Local tissue invasion is necessary but not sufficient for hematogenous metastasis.
Cells still face survival, transport, arrest, extravasation, and colonization challenges.
The overall inefficiency and complexity of successful metastasis.
Schematic
Local ECM invasion
Circulation
Distant colonization
Separate later steps
Slide 61 · Integrated mechanism: From cohesion loss to migration
E-cadherin loss / EMT-associated changes
Tumor- and stroma-derived proteolysis
Integrin binding to remodeled ECM
Actin-driven locomotion and vascular access
Sequential model of invasion (schematic)
Slide 62 · Predicting the effect of restoring cell adhesion
Which step of invasion would be most directly opposed if functional epithelial E-cadherin contacts were restored?
Mechanistic interpretation
The dissociation/loosening stage would be most directly opposed.
Effects on degradation or migration should not be assumed from E-cadherin restoration alone.
The invasion phenotype integrates multiple pathways.
Slide 63 · Predicting the effect of lower protease activity
What immediate ECM-level consequence is expected when functional matrix degradation is reduced?
Mechanistic interpretation
Basement membrane and interstitial matrix are less readily remodeled.
Generation of matrix cleavage fragments and liberation of stored factors may also decrease.
Compensation by other proteases or stromal pathways is possible.
Slide 64 · Predicting the effect of failed rear-edge release
A tumor cell makes new leading-edge attachments but cannot release its trailing edge. Why may net movement be impaired?
Mechanistic interpretation
Movement requires coordinated formation and disassembly of adhesions.
A persistently attached rear can oppose cell-body translocation.
Motility reflects the entire actin–adhesion cycle.
Slide 65 · Predicting the effect of impaired MET signaling
If HGF–MET motility signaling is reduced, which input is directly affected?
Mechanistic interpretation
The stromal HGF/scatter-factor paracrine motility input is affected.
Other autocrine or matrix-derived cues may still operate.
Robbins does not imply that MET is the only route to invasion.
Slide 66 · Four mechanisms, four representative molecules
Adhesion / proteolysis
E-cadherin: Epithelial cell–cell cohesion
MMP9: Collagen IV cleavage and growth-factor release
ECM interaction / movement
Integrins: Attachment and survival signaling
MET: Receptor for stromal HGF motility cue
Representative examples are not exclusive biomarkers of invasive cancer.
Slide 67 · Common interpretive errors
Do not equate reduced E-cadherin with proof of completed metastasis.
Do not treat MMP9 expression as a universal quantitative diagnostic cutoff.
Do not portray proteolysis as merely mechanical, or EMT as mandatory in every tumor.
Do not omit fibroblasts and immune cells from an invasion mechanism.
Slide 68 · Four-step mechanism at a glance
Cohesion decreases
ECM is proteolytically remodeled
Altered integrins engage new matrix sites
Cytoskeletal motility advances the tumor
A coordinated, microenvironment-dependent process leading toward vascular access.
Slide 69 · References and interpretation boundary
Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th ed. (2026), Chapter 7, “Invasion of Extracellular Matrix,” printed pp. 274–275.
Context: Chapter 7, “Invasion and Metastasis”; Chapter 1, ECM/integrin background.
Original editable schematics in this lecture are conceptual representations, not source-figure reproductions or histologic specimens.